Position in NVO
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$16,390,925
+$4,665,985 QoQ
Shares Held
341,905
+7.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#113
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cullen/Frost Bankers, Inc. holds $397,272,361 across 15 Drug Manufacturers - General names. NVO ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
101,158 | $121,331,950 | |
| 2 | ABBV |
AbbVie Inc.
|
341,851 | $86,023,385 | |
| 3 | JNJ |
Johnson & Johnson
|
308,337 | $78,308,347 | |
| 4 | MRK |
Merck & Co., Inc.
|
309,626 | $39,786,941 | |
| 5 | AMGN |
Amgen Inc
|
69,521 | $25,174,944 | |
| 6 | NVO |
Novo Nordisk A S
This page
|
341,905 | $16,390,925 | |
| 7 | AZN |
Astrazeneca PLC
|
84,701 | $16,061,003 | |
| 8 | PFE |
Pfizer Inc
|
209,637 | $5,048,058 |
All Filings in NVO
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,390,925 | 341,905 | Shares | Defined | 2026-07-27 | |
| 2026-03-31 | $11,724,940 | 319,046 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $8,518,431 | 167,422 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $6,402,602 | 115,383 | Shares | Defined | 2025-10-31 | |
| 2025-06-30 | $8,136,698 | 117,889 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $8,112,605 | 116,829 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $9,930,320 | 115,442 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $13,738,891 | 115,385 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $16,415,813 | 115,005 | Shares | Defined | 2024-08-05 | |
| 2024-03-31 | $14,701,800 | 114,500 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $11,846,473 | 114,514 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $10,410,447 | 114,476 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $9,539,393 | 58,947 | Shares | Defined | 2023-08-04 | |
| 2023-03-31 | $6,788,912 | 42,660 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $5,753,438 | 42,511 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,130,759 | 41,461 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $4,623,899 | 41,496 | Shares | Defined | 2022-08-05 | |
| 2022-03-31 | $4,629,008 | 41,684 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $4,690,336 | 41,878 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $4,170,482 | 43,438 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $3,795,534 | 45,309 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $4,438,325 | 65,831 | Shares | Other | 2021-05-05 | |
| 2020-12-31 | $4,427,791 | 63,390 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $4,299,383 | 61,924 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $3,834,966 | 58,567 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $1,066,382 | 17,714 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||